Introduction. The purpose of the study was to evaluate the trends in morbidity and mortality of the selected cancer sites in Poland against other European countries. Material and methods. Countries for analysis were selected based on geographical location. Estimates of age-adjusted incidence and mortality rates were calculated using the new European 2013 standard population. Lung, colorectal, breast, and prostate cancers were chosen. Time trends for age-standardized rates were analyzed using Joinpoint Regression software. Results. Poland differed from other analyzed countries mainly in terms of cancer mortality. Poland is a country with one of the smallest amounts of current expenditures on health care per capita, which translates into one...
Background: To update the pattern of cancer mortality in Europe. Materials and methods: We analysed ...
(1)Mortality data, abstracted from the World Health Organization database, are presented in tabular ...
Abstract BACKGROUND: Information on cancer prevalence is either absent or largely unavailable for ce...
Introduction.The purpose of the study was to evaluate the trends in morbidity and mortality of the s...
Introduction. The population of Poland’s oldest old has increased substantially in recent decades. W...
AbstractBackground and aimThe Greater Poland Region is one of the most industrialised areas of Polan...
SummaryGreater Poland is a region of high cancer risk in Poland. Standardized rates for cancer incid...
Background: The incidence of morbidity and mortality of cancers rapidly increase in the world and s...
Introduction. Survival rates are a tool that allows evaluation of healthcare quality and cancer trea...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
Cancer mortality rates and trends over the period 1980-2000 for accession countries to the European ...
Introduction. Morbidity due to malignant neoplasms has been growing steadily during the last three d...
Aim To collect cancer epidemiology data in South Eastern European countries as a basis for potential...
Mortality data, abstracted from the WHO database, are presented in tabular form for 26 cancer sites ...
Cancer mortality in Europe has been decreasing since the late 1980s or 1990s in some countries with ...
Background: To update the pattern of cancer mortality in Europe. Materials and methods: We analysed ...
(1)Mortality data, abstracted from the World Health Organization database, are presented in tabular ...
Abstract BACKGROUND: Information on cancer prevalence is either absent or largely unavailable for ce...
Introduction.The purpose of the study was to evaluate the trends in morbidity and mortality of the s...
Introduction. The population of Poland’s oldest old has increased substantially in recent decades. W...
AbstractBackground and aimThe Greater Poland Region is one of the most industrialised areas of Polan...
SummaryGreater Poland is a region of high cancer risk in Poland. Standardized rates for cancer incid...
Background: The incidence of morbidity and mortality of cancers rapidly increase in the world and s...
Introduction. Survival rates are a tool that allows evaluation of healthcare quality and cancer trea...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
Cancer mortality rates and trends over the period 1980-2000 for accession countries to the European ...
Introduction. Morbidity due to malignant neoplasms has been growing steadily during the last three d...
Aim To collect cancer epidemiology data in South Eastern European countries as a basis for potential...
Mortality data, abstracted from the WHO database, are presented in tabular form for 26 cancer sites ...
Cancer mortality in Europe has been decreasing since the late 1980s or 1990s in some countries with ...
Background: To update the pattern of cancer mortality in Europe. Materials and methods: We analysed ...
(1)Mortality data, abstracted from the World Health Organization database, are presented in tabular ...
Abstract BACKGROUND: Information on cancer prevalence is either absent or largely unavailable for ce...